Cancer Research Technology has signed a further deal with Merck to discover new cancer drugs targeting the Hippo pathway.
An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today.
Cancer Research UK launches the second phase of its global Grand Challenge, with eight new questions identified as some of the biggest barriers to progress.
Cancer Research UK is pleased to announce the appointment of Professor Charles Swanton as its new chief clinician.
Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.